prior_authorization_request_form_tyenne
This document is a Cigna prior authorization request form for Tyenne (tocilizumab) intravenous vials, to be completed by prescribers requesting coverage/authorization across multiple indicated diagnoses and care settings. It collects patient, prescriber, clinical, prior-therapy, administration site, and pharmacy sourcing information required for review.
No material clinical/coverage changes in this prior authorization form.
Tyenne (tocilizumab) prior authorization request form — summary
This is a Cigna prior authorization request form for Tyenne (tocilizumab) intravenous vials, to be completed by prescribers requesting medical coverage/authorization across multiple rheumatologic and inflammatory diagnoses and care settings. The form requires completion of patient and prescriber identification and contact fields (asterisked items are required for privacy-regulated responses), selection of the specific Tyenne vial presentation requested (80 MG/4 ML, 200 MG/10 ML, or 400 MG/20 ML), the indication/diagnosis, whether this is a new start or continuation, and documentation of clinical status. It collects prior therapy details (drug name, strength, dates, duration, results, intolerances/contraindications), specialist involvement or attestations (for example, rheumatologist, oncologist, or disease-specific specialist), intended administration site (home, physician office, hospital outpatient, other), and where the medication will be obtained (including Accredo specialty pharmacy, hospital outpatient, retail, home health/home infusion, physician office stock, or other) to inform coverage and site-of-care decisions.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.